PRAC Confirms No Difference in Risk Between Hemophilia A Drugs

PRAC Confirms No Difference in Risk Between Hemophilia A DrugsThe EMA’s Pharmacovigilance Risk Assessment Committee has confirmed its earlier conclusion that factor VIII medications do not differ in their risk for inhibition.
News AlertsThe EMA’s Pharmacovigilance Risk Assessment Committee has confirmed its earlier conclusion that factor VIII medications do not differ in their risk for inhibition.
News Alerts
Go to Source
Author:

Powered by WPeMatico